Koshinski Asset Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.52M | Buy |
146,261
+92,432
| +172% | +$2.42M | 0.19% | 114 |
|
|
2026
Q1 | $1.51M | Buy |
53,829
+13,843
| +35% | +$369K | 0.09% | 197 |
|
|
2025
Q4 | $996K | Buy |
39,986
+6,742
| +20% | +$170K | 0.06% | 277 |
|
|
2025
Q3 | $847K | Buy |
33,244
+2,268
| +7% | +$56K | 0.06% | 303 |
|
|
2025
Q2 | $751K | Buy |
30,976
+7,768
| +33% | +$181K | 0.06% | 322 |
|
|
2025
Q1 | $588K | Buy |
23,208
+1,995
| +9% | +$52.2K | 0.05% | 339 |
|
|
2024
Q4 | $563K | Sell |
21,213
-2,789
| -12% | -$75.7K | 0.05% | 339 |
|
|
2024
Q3 | $695K | Buy |
24,002
+266
| +1% | +$7.76K | 0.06% | 307 |
|
|
2024
Q2 | $658K | Sell |
23,736
-529
| -2% | -$14.6K | 0.06% | 287 |
|
|
2024
Q1 | $673K | Buy |
24,265
+4,130
| +21% | +$115K | 0.07% | 272 |
|
|
2023
Q4 | $580K | Sell |
20,135
-8,517
| -30% | -$257K | 0.09% | 255 |
|
|
2023
Q3 | $950K | Sell |
28,652
-775
| -3% | -$27.4K | 0.11% | 189 |
|
|
2023
Q2 | $1.08M | Sell |
29,427
-13,552
| -32% | -$527K | 0.12% | 182 |
|
|
2023
Q1 | $1.75M | Sell |
42,979
-6,328
| -13% | -$273K | 0.17% | 125 |
|
|
2022
Q4 | $2.53M | Sell |
49,307
-1,703
| -3% | -$81.6K | 0.24% | 100 |
|
|
2022
Q3 | $2.23M | Sell |
51,010
-1,139
| -2% | -$55.3K | 0.27% | 97 |
|
|
2022
Q2 | $2.73M | Sell |
52,149
-6,724
| -11% | -$343K | 0.27% | 99 |
|
|
2022
Q1 | $3.05M | Buy |
58,873
+305
| +0.5% | +$15.8K | 0.25% | 92 |
|
|
2021
Q4 | $3.46M | Buy |
58,568
+3,911
| +7% | +$194K | 0.28% | 81 |
|
|
2021
Q3 | $2.35M | Buy |
54,657
+20,168
| +58% | +$893K | 0.2% | 109 |
|
|
2021
Q2 | $1.35M | Sell |
34,489
-8,844
| -20% | -$344K | 0.17% | 142 |
|
|
2021
Q1 | $1.57M | Buy |
43,333
+6,274
| +17% | +$223K | 0.17% | 149 |
|
|
2020
Q4 | $1.36M | Buy |
37,059
+4,598
| +14% | +$169K | 0.17% | 148 |
|
|
2020
Q3 | $1.13M | Buy |
32,461
+2,496
| +8% | +$87.5K | 0.15% | 158 |
|
|
2020
Q2 | $930K | Buy |
29,965
+4,858
| +19% | +$165K | 0.15% | 173 |
|
|
2020
Q1 | $778K | Sell |
25,107
-2,281
| -8% | -$77.7K | 0.16% | 167 |
|
|
2019
Q4 | $1.01M | Buy |
27,388
+10,933
| +66% | +$389K | 0.17% | 180 |
|
|
2019
Q3 | $561K | Buy |
16,455
+2,005
| +14% | +$72.9K | 0.39% | 78 |
|
|
2019
Q2 | $594K | Sell |
14,450
-5,745
| -28% | -$228K | 0.24% | 127 |
|
|
2019
Q1 | $814K | Sell |
20,195
-28,740
| -59% | -$1.15M | 0.22% | 132 |
|
|
2018
Q4 | $2.03M | Sell |
48,935
-207,564
| -81% | -$8.62M | 0.5% | 63 |
|
|
2018
Q3 | $10.7M | Buy |
256,499
+124,339
| +94% | +$4.79M | 1.53% | 3 |
|
|
2018
Q2 | $4.55M | Sell |
132,160
-3,310
| -2% | -$113K | 1.39% | 3 |
|
|
2018
Q1 | $4.56M | Sell |
135,470
-34,426
| -20% | -$1.18M | 1.42% | 2 |
|
|
2017
Q4 | $5.84M | Buy |
169,896
+12,546
| +8% | +$428K | 1.46% | 2 |
|
|
2017
Q3 | $5.33M | Buy |
157,350
+110,743
| +238% | +$3.56M | 1.75% | 2 |
|
|
2017
Q2 | $1.49M | Buy |
46,607
+11,825
| +34% | +$373K | 0.54% | 47 |
|
|
2017
Q1 | $1.13M | Buy |
34,782
+6,899
| +25% | +$218K | 0.44% | 66 |
|
|
2016
Q4 | $859K | Sell |
27,883
-2,378
| -8% | -$72.6K | 0.43% | 69 |
|
|
2016
Q3 | $972K | Buy |
30,261
+1,626
| +6% | +$54.4K | 0.48% | 61 |
|
|
2016
Q2 | $957K | Buy |
28,635
+294
| +1% | +$9.38K | 0.52% | 52 |
|
|
2016
Q1 | $798K | Buy |
28,341
+15,432
| +120% | +$441K | 0.52% | 61 |
|
|
2015
Q4 | $395K | Buy |
12,909
+23
| +0.2% | +$724 | 0.28% | 114 |
|
|
2015
Q3 | $410K | Sell |
12,886
-268
| -2% | -$8.59K | 0.26% | 118 |
|
|
2015
Q2 | $418K | Buy |
13,154
+147
| +1% | +$4.79K | 0.26% | 116 |
|
|
2015
Q1 | $429K | Sell |
13,007
-6,453
| -33% | -$205K | 0.28% | 105 |
|
|
2014
Q4 | $575K | Buy |
+19,460
| New | +$558K | 0.33% | 84 |
|
Other funds holding PFE
Koshinski Asset Management's PFE Position: Q2 2026 in Review
Koshinski Asset Management increased its Pfizer (PFE) stake by 172% in Q2 2026, buying an estimated $2.42M and bringing the position to 146,261 shares worth $3.52M. The position accounts for 0.19% of the portfolio, ranked #114.
Koshinski Asset Management first reported a position in PFE in Q4 2014 and has held it in 47 quarters since. The position peaked at $10.7M in Q3 2018. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Koshinski Asset Management held 146,261 shares of Pfizer worth $3.52M as of Q2 2026.
- Koshinski Asset Management bought 92,432 Pfizer shares in Q2 2026, an estimated $2.42M.
- Pfizer made up 0.19% of Koshinski Asset Management's portfolio in Q2 2026, its #114 holding.
- Koshinski Asset Management first reported a position in Pfizer in Q4 2014 and has held it in 47 quarters since.
- Koshinski Asset Management's Pfizer position peaked at $10.7M in Q3 2018.
- 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Koshinski Asset Management's 13F filing for Q2 2026, filed 27 Jul 2026.